88IV - PR Newswire Asia's news


Insilico Medicine Nominates ISM0900, a Potent, AI-driven, Oral Lp(a) Inhibitor, as PCC for Management of Cardiovascular Risks CAMBRIDGE, Mass. , Aug. 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company , today ... 2026-08-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Beyang Closes Oversubscribed $30 Million Series A Financing Funding to accelerate the iteration of the proprietary AI-driven ExCEED platform and advance global clinical development of differentiated pipelines, including a second-generation Menin inhibitor ... 2026-08-12T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Beyang Closes Oversubscribed $30 Million Series A Financing Funding to accelerate the iteration of the proprietary AI-driven ExCEED platform and advance global clinical development of differentiated pipelines, including a second-generation Menin inhibitor ... 2026-08-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Senhwa's CX-5461 Opens a New Frontier in Photoimmunotherapy; Multinational Study Published in Nucleic Acids Research TAIPEI and SAN DIEGO , Aug. 12, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. ( TPEx : 6492) today announced a significant research advance involving its investigational drug Pidnarulex (CX-5461). ... 2026-08-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
BASF Agricultural Solutions invests in new Climate Center at its headquarters to strengthen research capabilities State-of-the-art research facility at Limburgerhof site responds to increasing regulatory and research demands Purpose-built facility will enable controlled, reproducible ecotoxicology studies to ... 2026-08-12T Agriculture Banking/Financial Service Biotechnology Chemical
New Drug Application for LAE002 (afuresertib) Accepted by China's National Medical Products Administration SHANGHAI , Aug. 12, 2026 /PRNewswire/ -- Laekna (2105.HK) announced today that the New Drug Application (NDA) for LAE002 (afuresertib) has been accepted by the Center for Drug Evaluation (CDE) of China's ... 2026-08-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Metabolon Launches Peak Science Grant Program to Advance Breakthrough Metabolomics Research Quarterly grant program provides researchers with no-cost access to Metabolon's industry-leading metabolomics platform, scientific expertise, bioinformatics tools, and data interpretation resources ... 2026-08-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Bracco Marks Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for VueJect®, the First Dedicated Ultrasound Contrast Delivery System to Support Cardiology Imaging VueJect ® strengthens Bracco's integrated CEUS ecosystem by enabling more standardized, efficient contrast administration in cardiology imaging ... 2026-08-11T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Korean Biotech Company K-Medichem Expands Global Market Reach with PDRN Derma Skincare Line in Vietnam, Indonesia and Beyond PDRN Derma cream, serum, and mask lineup positions premium K-dermocosmetics based on patented ingredients for Southeast Asian market expansion CHUNCHEON, South Korea , Aug. 11, 2026 /PRNewswire/ ... 2026-08-11T Biotechnology Cosmetics & Personal Care Health Care/Hospital Medical Equipment
Cambrex Milan Celebrates 80th Anniversary with Construction of New $30 Million R&D Facility EAST RUTHERFORD, N.J. , Aug. 11, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced the start of construction on a new research ... 2026-08-11T Biotechnology Construction/Building Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology